Photo: Vladimir Song / RIA Novosti
Treatment of patients with coronavirus with plasma transfusions from survivors best when to carry out this procedure in the beginning. The details of the treatment he revealed in an interview with owned by Grigory Berezkin RBC Deputy General Director on scientific work and medical technology scientific clinical center, Federal medical-biological Agency, doctor of medical Sciences Vladimir Baklaushev1.
He said that now the Agency conducted a study of the effectiveness of transfusion to patients blood plasma recovered COVID-19 patients. Transfusion select those who have a very high temperature for several days. At this stage, if the doctors continue symptomatic treatment and not proceed to the treatment of causes of disease, the next step could be the development of respiratory failure, and “the progression of this failure, the necessity of transferring the patient to the intensive care unit, intubation, assisted ventilation”.
In this case, the patient needs to be transferred to the intensive care unit on a ventilator. For these occur between the ages plasma, introduced at the initial stage, to be effective, the expert noted.
However, he said that the guarantee of the efficiency is not 100 percent, but the result of the treatment is still there. It is best to test fit the blood plasma of those patients who suffered COVID-19 in the form of light, but still with symptoms of pneumonia. In this case, those who have the disease is asymptomatic or very hard, for donation are not suitable.
The expert also said that the plasma will not help if it is to transfuse the patient, who is on a ventilator for more than two days and who developed respiratory distress syndrome and severe damage to the lung tissue.
On 20 March it was reported that in Moscow, donors of plasma for treatment of patients with coronavirus are more than 540 people. The Department of health has also estimated the number of patients who spent the transfusion of immune plasma is 340 people.
Video, photo All from Russia.